Doctor profile · Federal record

Dr. Sam Bebawy, MD FCCP

Pulmonary Disease Physician (CMS: Pulmonary Disease) · Critical Care Medicine (Internal Medicine) Physician · Sleep Specialist (PHD) · Holmdel, NJ

  • NPI 1396717971
  • Accepts Medicare
  • MIPS 60.0 / 100 · 2023
  • 50 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
719 N Beers St, Suites 2E & 2F
Holmdel, NJ 07733
(732) 264-1001
fax (732) 264-4495

Credentials & registration

NPPES · NUCC
NPI registered
February 2006 — 20 yrs on file
Profile last updated
June 24, 2010
Year of graduation
1976 — 50 yrs since
Specialty taxonomy
207RP1001X — NUCC code
State license (1)
New Jersey #25MA04909400
Medicaid
NJ #6681506

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1396717971. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,211
Distinct HCPCS
7
Medicare allowed
$90,666
HCPCS Description Services Patients Avg allowed
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days 662 81 $56
99214 Established patient office or other outpatient visit, 30-39 minutes 284 176 $137
94060 Test to measure expiratory airflow and volume changes before and after medication administration 77 75 $43
94727 Test to determine lung volumes using gas dilution or washout 77 75 $48
94729 Test to examine how well the lungs exchange gases 77 75 $63
95800 Sleep study including heart rate, breathing, and sleep time 19 19 $42
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) 15 15 $128

In context: peer comparison

Among 3 peers in this city , average services per provider: 240. This provider delivers 5.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,951
Transactions
101
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 24 $1,153.55
GlaxoSmithKline, LLC. 12 $400.89
Noah Medical Corporation 1 $184.95
GENZYME CORPORATION 10 $178.75
Mallinckrodt Hospital Products Inc. 12 $173.94
Actelion Pharmaceuticals US, Inc. 9 $145.82
United Therapeutics Corporation 4 $143.24
Boehringer Ingelheim Pharmaceuticals, Inc. 6 $101.92
Electromed, Inc. 6 $98.76
Inspire Medical Systems, Inc. 4 $83.55
Insmed, Inc. 3 $51.97
HARMONY BIOSCIENCES LLC 3 $48.14
Optinose US, Inc. 3 $47.99
Baxter Healthcare 2 $36.32
Mylan Specialty L.P. 2 $34.51

By nature of payment

Food and Beverage
$2,951

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
556
Patients
78
Total drug cost
$111,618
Drug Type Claims Patients Total cost
Rosuvastatin Calcium Generic 76 18 $1,079
Ipratropium-Albuterol (Ipratropium/Albuterol Sulfate) Brand 68 0 $317
Montelukast Sodium Generic 62 16 $603
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 55 12 $56,551
Atorvastatin Calcium Generic 50 14 $475
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 34 18 $1,307
Levothyroxine Sodium Generic 30 0 $647
Pantoprazole Sodium Generic 29 0 $539
Symbicort (Budesonide/Formoterol Fumarate) Brand 28 0 $13,992
Breo Ellipta (Fluticasone/Vilanterol) Brand 24 0 $24,915

Frequently asked questions

Auto-generated from federal data
What is Dr. Sam Bebawy's medical specialty?
Dr. Sam Bebawy practices Pulmonary Disease Physician in Holmdel, NJ.
Where does Dr. Sam Bebawy practice?
Dr. Sam Bebawy practices at 719 N Beers St, Holmdel, NJ 07733. Office phone: 7322641001.
What is Dr. Sam Bebawy's NPI?
Dr. Sam Bebawy's National Provider Identifier (NPI) is 1396717971, issued by NPPES.
Does Dr. Sam Bebawy accept Medicare assignment?
Yes. Dr. Sam Bebawy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sam Bebawy commonly perform?
Top Medicare-reported procedures in 2023: Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS 99454); Established patient office or other outpatient visit (HCPCS 99214); Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS 94060). Source: CMS Medicare Physician & Other Practitioners file.